Evidence map›Paper›PMID 27466423›Full record

ArticleJournal of virology2016

Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

Wenhui He, Zhiliang Cao, Fengfeng Mao, Bijie Ren, Yunfei Li, Dan Li, Huiyu Li, Bo Peng, Huan Yan, Yonghe Qi and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Hepatitis B and D virus entry.Nature reviews. Microbiology · 2025
    Review
  7. Article
  8. Hepatitis B virus entry, assembly, and egress.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Multitasking NaBiomedicines · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Wenhui HePostdoctoral Program, School of Life Sciences, Peking University, Beijing, China National Institute of Biological Sciences, Beijing, China.
Zhiliang CaoNational Institute of Biological Sciences, Beijing, China.
Fengfeng MaoNational Institute of Biological Sciences, Beijing, China Graduate Program, School of Life Sciences, Beijing Normal University, Beijing, China.
Bijie RenNational Institute of Biological Sciences, Beijing, China.
Yunfei LiNational Institute of Biological Sciences, Beijing, China.
Dan LiNational Institute of Biological Sciences, Beijing, China Graduate Program, School of Life Sciences, Tsinghua University, Beijing, China.
Huiyu LiNational Institute of Biological Sciences, Beijing, China.
Bo PengNational Institute of Biological Sciences, Beijing, China Graduate Program, School of Life Sciences, Peking University, Beijing, China.
Huan YanNational Institute of Biological Sciences, Beijing, China.
Yonghe QiNational Institute of Biological Sciences, Beijing, China.
Yinyan SunNational Institute of Biological Sciences, Beijing, China.
Fengchao WangNational Institute of Biological Sciences, Beijing, China.
Jianhua SuiNational Institute of Biological Sciences, Beijing, China Graduate Program, School of Life Sciences, Tsinghua University, Beijing, China suijianhua@nibs.ac.cn liwenhui@nibs.ac.cn.
Wenhui LiNational Institute of Biological Sciences, Beijing, China Graduate Program, School of Life Sciences, Beijing Normal University, Beijing, China Graduate Program, School of Life Sciences, Peking University, Beijing, China suijianhua@nibs.ac.cn liwenhui@nibs.ac.cn.
National Institute of Biological Sciences, Beijing · CNPeking University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledSodium taurocholate cotransporting polypeptide (NTCP) was identified as a functional receptor for hepatitis D virus (HDV) and its helper hepatitis B virus (HBV). In cultured cell lines, HDV infection through mouse NTCP is restricted by residues 84 to 87 of the receptor. This study shows that mice with these three amino acids altered their corresponding human residues (H84R, T86K, and S87N) in endogenous mouse NTCP support de novo HDV infection in vivo HDV infection was documented by the presence of replicative forms of HDV RNA and HDV proteins in liver cells at day 6 after viral inoculation. Monoclonal antibody specifically binding to the motif centered on K86 in NTCP partially inhibited HDV infection. These studies demonstrated specific interaction between the receptor and the viral envelopes in vivo and established a novel mouse model with minimal genetic manipulation for studying HDV infection. The model will also be useful for evaluating entry inhibitors against HDV and its helper HBV. IMPORTANCE: NTCP was identified as a functional receptor for both HDV and HBV in cell cultures. We recently showed that neonatal C57BL/6 transgenic (Tg) mice exogenously expressing human NTCP (hNTCP-Tg) in liver support transient HDV infection. In this study, we introduced alterations of three amino acids in the endogenous NTCP of FVB mice through genome editing. The mice with the humanized NTCP residues (H84R, T86K, and S87N) are susceptible to HDV infection, and the infection can be established in both neonatal and adult mice with this editing. We also developed a monoclonal antibody specifically targeting the region of NTCP centered on lysine residue 86, and it can differentiate the modified mouse NTCP from that of the wild type and partially inhibited HDV infection. These studies shed new light on NTCP-mediated HDV infection in vivo, and the NTCP-modified mice provide a useful animal model for studying HDV infection and evaluating antivirals against the infection.

Indexed as

Amino Acid SubstitutionAnimalsDisease Models, AnimalDisease SusceptibilityHepatitis DHepatitis Delta VirusMiceMutant ProteinsOrganic Anion Transporters, Sodium-DependentReceptors, VirusSymportersMutant ProteinsOrganic Anion Transporters, Sodium-DependentReceptors, Virussodium-bile acid cotransporterSymporters

Identifiers

PMID27466423
PMCPMC5021397
OpenAlexW2480651115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.